Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin.

Literature DB >> 16247814

Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin.

Sebastian Dziadek¹, Danuta Kowalczyk, Horst Kunz.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2005 PMID： 16247814 DOI： 10.1002/anie.200501593

Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN： 1433-7851 Impact factor: 15.336

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy.

Authors: Mingjing Li; Zhaoyu Wang; Bocheng Yan; Xiaona Yin; Yue Zhao; Fan Yu; Meng Meng; Yonghui Liu; Wei Zhao
Journal: Medchemcomm Date: 2019-07-12 Impact factor: 3.597

2. Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.

Authors: Raymond P Brinãs; Andreas Sundgren; Padmini Sahoo; Susan Morey; Kate Rittenhouse-Olson; Greg E Wilding; Wei Deng; Joseph J Barchi
Journal: Bioconjug Chem Date: 2012-07-31 Impact factor: 4.774

Review 3. Cancer-associated mucins: role in immune modulation and metastasis.

Authors: Rakesh Bhatia; Shailendra K Gautam; Andrew Cannon; Christopher Thompson; Bradley R Hall; Abhijit Aithal; Kasturi Banerjee; Maneesh Jain; Joyce C Solheim; Sushil Kumar; Surinder K Batra
Journal: Cancer Metastasis Rev Date: 2019-06 Impact factor: 9.264

10. Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses.

Authors: Jing-Jing Du; Chang-Wei Wang; Wen-Bo Xu; Lian Zhang; Yuan-Kai Tang; Shi-Hao Zhou; Xiao-Fei Gao; Guang-Fu Yang; Jun Guo
Journal: iScience Date: 2020-02-24

10 in total

Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin.

1. Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy.

2. Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.

Review 3. Cancer-associated mucins: role in immune modulation and metastasis.

4. Robust immune responses elicited by a fully synthetic three-component vaccine.

5. Synthesis of glycosylated β³-homo-threonine conjugates for mucin-like glycopeptide antigen analogues.

6. Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.

Review 7. Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines.

8. Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine.

9. Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity.

10. Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses.